Articles
RFID Reader Prevents Reagent Counterfeiting In Healthcare Industry
April 9, 2007
•Case Study: Iris Diagnostics
Cloning and counterfeiting pose perhaps the greatest threat in the healthcare industry where decreased reliability and performance of medical devices and medication affect diagnosis and treatment. The downstream effects are decreased patient safety, insurance cost efficiency, and provider reputations.
Iris Diagnostics, a division of Iris International (NASDAQ: IRIS), is tackling the cloning problem head-on by RFID-enabling their iQ®200 Automated Urinalysis System. Utilizing chemical reagents to detect the presence of molecules in urine samples, the machine relies on reagents of the correct type, freshness, and authenticity in order to deliver the most accurate results. To prevent reagent counterfeiting, Iris Diagnostics is incorporating SkyeTek's RFID reader and ReaderWare Security technology into their product.
Click Here To Download:•Case Study: Iris Diagnostics
